(Q80724523)
Statements
A randomized, double-blind, placebo-controlled trial of a COX-2 inhibitor (Rofecoxib) in patients undergoing coronary artery bypass surgery (English)
Poo-Sing Wong
Atasha Asmat
scientific article published on 23 December 2005
No description defined